Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „Mylan“
Suchtreffer
Begriffe & Kennungen
Amlodipine / Valsartan Mylan · 4.8 · Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be p
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Amlodipine Common Somnolence, dizziness, palpitations, abdominal pain, nausea, ankle swelling. Uncommon Insomn
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Exceptional cases of extrapyramidal syndrome have been reported.
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · MedDRA Adverse reactions Frequency System organ Amlodipine/Valsartan Amlodipine Valsartan class Infections and
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Peripheral oedema, a recognised adverse reaction of amlodipine, was generally observed at a lower incidence in
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Summary of the safety profile
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · The mean incidence of peripheral oedema evenly weighted across all doses was 5.1 % with the amlodipine/valsart
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · The safety of amlodipine/valsartan has been evaluated in five controlled clinical studies with 5,175 patients,
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Valsartan Not known Decrease in haemoglobin, decrease in haematocrit, neutropenia, thrombocytopenia, increase
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan)
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.1 Therapeutic indications · 1
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 Contraindications · 1
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 · 4 Atazanavir Viatris is contraindicated in patients with severe hepatic insufficiency (see sections 4.2, 4.4 a
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 · Co-administration with glecaprevir/pibrentasvir fixed-dose combination (see section 4.5).
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 · Co-administration with grazoprevir-containing products, including elbasvir/grazoprevir fixed-dose combination
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 · Co-administration with medicinal products that are strong inducers of CYP3A4 due to the potential for loss of
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 · Co-administration with medicinal products that are substrates of the CYP3A4 isoform of cytochrome P450 and hav
Eintrag öffnen